Eledon Pharmaceuticals, Inc. (ELDN) vs Upstream Bio, Inc. (UPB)
- Eledon Pharmaceuticals, Inc. ELDN 2.27 +0.89%
- Upstream Bio, Inc. UPB 3.38 −1.17%
Eledon Pharmaceuticals, Inc. and Upstream Bio, Inc. are both Biotechnology companies. Eledon Pharmaceuticals, Inc. and Upstream Bio, Inc. are of similar size ($190.2M and $187.3M). Eledon Pharmaceuticals, Inc. has the higher net margin (0.00% vs −4,955.7%) and the higher return on invested capital (0.00% vs −1,100.9%). Across the 13 metrics below, Eledon Pharmaceuticals, Inc. leads on 7 and Upstream Bio, Inc. on 6.
Valuation
Profitability
| Metric | ELDN | UPB | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (5,382.65%) | 0.00% |
| Net margin | 0.00% | (4,955.67%) | 0.00% |
| Free cash flow margin | 0.00% | (4,317.42%) | 0.00% |
| Return on equity | (236.51%) | (46.05%) | (56.36%) |
| Return on assets | (72.74%) | (44.61%) | (48.04%) |
| Return on invested capital | 0.00% | (1,100.93%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack